| Code | CSB-RA978157A0HU |
| Size | US$210 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
| Application | Recommended Dilution |
|---|---|
| IHC | 1:50-1:200 |
| IF | 1:20-1:200 |
MYBBP1A, also known as Myb-binding protein 1A or P160, serves as a critical transcriptional regulator that influences diverse cellular processes including ribosome biogenesis, cell cycle progression, and stress response pathways. This nucleolar protein interacts with key transcription factors and has emerged as a significant player in cancer biology, where its expression levels correlate with tumor progression and cellular proliferation. For researchers investigating epigenetic regulation, nuclear signaling cascades, or oncogenic mechanisms, reliable detection of MYBBP1A is essential for understanding its functional contributions.
This recombinant monoclonal antibody, generated in rabbit against a synthetic peptide derived from human MYBBP1A, offers the consistency and reproducibility that demanding research applications require. Because the antibody sequence is defined and produced recombinantly, you can expect uniform performance across experiments and between lots, eliminating the variability that can complicate long-term studies or multi-site collaborations. The monoclonal nature ensures specificity for a single epitope, providing clean, interpretable results.
Validation studies demonstrate versatility across tissue and cellular imaging workflows. Immunohistochemistry performed on paraffin-embedded human kidney tissue using a citrate buffer antigen retrieval protocol shows specific staining at dilutions between 1:50 and 1:200. Immunofluorescence analysis in HepG2 cells reveals clear signal with DAPI counterstaining, confirming utility for subcellular localization studies in hepatocellular carcinoma models. The antibody is also validated for ELISA applications.
Supplied in a glycerol-containing buffer optimized for long-term stability, this affinity-purified antibody is well-suited for investigations spanning cancer biology, signal transduction research, and epigenetic studies where consistent MYBBP1A detection is fundamental to experimental success.
There are currently no reviews for this product.